Katrin Eckhardt

1.3k total citations
15 papers, 875 citations indexed

About

Katrin Eckhardt is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Katrin Eckhardt has authored 15 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Biomaterials. Recurrent topics in Katrin Eckhardt's work include Glycosylation and Glycoproteins Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Katrin Eckhardt is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Katrin Eckhardt collaborates with scholars based in Switzerland, Germany and Czechia. Katrin Eckhardt's co-authors include Wilhelm Krek, Roland H. Wenger, Jianru Stahl-Zeng, Bruno Domon, Vinzenz Lange, Ruedi Aebersold, Reto Ossola, Dörthe M. Katschinski, Tobias Linden and Falk Martin and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Blood.

In The Last Decade

Katrin Eckhardt

15 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin Eckhardt Switzerland 9 505 248 149 122 96 15 875
Ma Carmen Durán-Ruiz Spain 17 583 1.2× 221 0.9× 190 1.3× 149 1.2× 20 0.2× 44 1.1k
Huazong Zeng China 16 849 1.7× 137 0.6× 464 3.1× 66 0.5× 23 0.2× 23 1.2k
Magdalena Łuczak Poland 20 466 0.9× 66 0.3× 137 0.9× 50 0.4× 21 0.2× 49 878
Jan Österreicher Czechia 16 470 0.9× 51 0.2× 143 1.0× 78 0.6× 23 0.2× 53 996
Jinxiang Han China 14 412 0.8× 58 0.2× 170 1.1× 80 0.7× 13 0.1× 34 814
Jean Bowen United States 3 348 0.7× 92 0.4× 125 0.8× 32 0.3× 36 0.4× 4 625
Sean C. Sapcariu Luxembourg 7 491 1.0× 48 0.2× 149 1.0× 30 0.2× 21 0.2× 8 841
J.P. Borel France 17 246 0.5× 48 0.2× 151 1.0× 51 0.4× 36 0.4× 41 767
Danjun Ma China 18 523 1.0× 67 0.3× 215 1.4× 106 0.9× 7 0.1× 38 883

Countries citing papers authored by Katrin Eckhardt

Since Specialization
Citations

This map shows the geographic impact of Katrin Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Eckhardt more than expected).

Fields of papers citing papers by Katrin Eckhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Eckhardt. The network helps show where Katrin Eckhardt may publish in the future.

Co-authorship network of co-authors of Katrin Eckhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Eckhardt. A scholar is included among the top collaborators of Katrin Eckhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Eckhardt. Katrin Eckhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Colombo, Ilaria, Simon Haefliger, Manuela Rabaglio, et al.. (2024). TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16). European Journal of Cancer. 201. 113588–113588. 10 indexed citations
2.
Hess, Dagmar, Robin Michelet, Ilaria Colombo, et al.. (2024). Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial. Cancer Chemotherapy and Pharmacology. 94(3). 349–360. 5 indexed citations
3.
Hess, Dagmar, Ilaria Colombo, Simon Haefliger, et al.. (2022). TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).. Journal of Clinical Oncology. 40(16_suppl). 3027–3027. 1 indexed citations
4.
Eckhardt, Katrin, et al.. (2022). Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor. ChemBioChem. 24(1). e202200553–e202200553. 6 indexed citations
5.
Eckhardt, Katrin, Klaus‐Peter Zeller, Hans‐Ullrich Siehl, Stefan Berger, & Dieter Sicker. (2017). Berberinchlorid aus Berberitzenrinde. Chemie in unserer Zeit. 51(5). 344–356. 2 indexed citations
6.
Hitz, Felicitas, Emanuele Zucca, Thomas Pabst, et al.. (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B‐cell lymphoma not eligible for anthracycline‐based therapy or intensive salvage chemotherapy – SAKK 38/08. British Journal of Haematology. 174(2). 255–263. 7 indexed citations
7.
Eckhardt, Katrin, Klaus‐Peter Zeller, Hans‐Ullrich Siehl, Stefan Berger, & Dieter Sicker. (2016). Ein Wirkstoff gegen Malaria aus der Natur: Artemisinin. Chemie in unserer Zeit. 50(5). 326–335. 1 indexed citations
8.
Eckhardt, Katrin, et al.. (2011). Substrate preference and phosphatidylinositol monophosphate inhibition of the catalytic domain of the Per‐Arnt‐Sim domain kinase PASKIN. FEBS Journal. 278(10). 1757–1768. 13 indexed citations
9.
Danzer, Carsten Friedrich, Katrin Eckhardt, Alexander Schmidt, et al.. (2011). Comprehensive Description of the N-Glycoproteome of Mouse Pancreatic β-Cells and Human Islets. Journal of Proteome Research. 11(3). 1598–1608. 27 indexed citations
10.
Danzer, Carsten Friedrich, Stephan C. Collins, Katrin Eckhardt, et al.. (2008). pVHL is a regulator of glucose metabolism and insulin secretion in pancreatic β cells. Genes & Development. 22(22). 3135–3146. 78 indexed citations
11.
Stahl-Zeng, Jianru, Vinzenz Lange, Reto Ossola, et al.. (2007). High Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N-Glycosites. Molecular & Cellular Proteomics. 6(10). 1809–1817. 301 indexed citations
12.
Eckhardt, Katrin, Dörthe M. Katschinski, Klaus Wagner, et al.. (2007). Male Germ Cell Expression of the PAS Domain Kinase PASKIN and its Novel Target Eukaryotic Translation Elongation Factor eEF1A1. Cellular Physiology and Biochemistry. 20(1-4). 227–240. 25 indexed citations
13.
Martin, Falk, Tobias Linden, Dörthe M. Katschinski, et al.. (2005). Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood. 105(12). 4613–4619. 272 indexed citations
14.
Marti, Hugo H., Klaus Wagner, Katrin Eckhardt, et al.. (2003). Targeted Disruption of the Mouse PAS Domain Serine/Threonine Kinase PASKIN. Molecular and Cellular Biology. 23(19). 6780–6789. 36 indexed citations
15.
Linden, Tobias, Dörthe M. Katschinski, Katrin Eckhardt, et al.. (2003). The antimycotic ciclopirox olamine induces HIF‐1α stability, VEGF expression, and angiogenesis. The FASEB Journal. 17(6). 761–763. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026